Sign Up Today and Learn More About ScienceIO Stock
Invest in or calculate the value of your shares in ScienceIO or other pre-IPO companies through EquityZen's platform.
ScienceIO Stock (SCIO)
The data science company for healthcare
ScienceIO is a datas science company
About ScienceIO Stock
Founded
2019
Headquarters
Boston, MA, US
Total Funding
22.1M
Industries
Software, Artificial Intelligence, Data and Analytics
ScienceIO is a data science company that uses AI to help healthcare providers and payors organize large amounts of patient data. The company's mission is to help healthcare providers improve workflows and deliver better patient outcomes. The company claims to take a data-first approach to artificial intelligence, building the technology necessary to turn disparate healthcare data into high-quality, computable data.
ScienceIO was founded in 2019 by Will Manidis and Gaurav Kaushik and is headquartered in Boston, MA. Notable investors include  Section 32 and Sea Lane Ventures.
ScienceIO Press Mentions
Stay in the know about the latest news on ScienceIO
InnovationRx: Chelsea Clinton Invests In 24/7 Pediatrics Startup
forbes • Jun 04, 2024
Veradigm and ScienceIO say AI may redefine the function of EHRs
fiercehealthcare • Jun 04, 2024
Veradigm to acquire generative AI company ScienceIO for $140M
modernhealthcare • May 19, 2024
Inside Medical Records Company Veradigm's Huge AI Gamble On ScienceIO
forbes • May 19, 2024
Eye On AI: After Q4 Slowdown, AI-Related M&A Picked Back Up In Q1
news • May 02, 2024
ScienceIO Management
Leadership team at ScienceIO
Founder & CEO
Will Manidis
Founder, President & COO
Gaurav Kaushik
Join now and verify your accreditation status to gain access to:
- ScienceIO current valuation
- ScienceIO stock price
- Available deals in ScienceIO and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in ScienceIO stock?
Accredited investors can buy pre-IPO stock in companies like ScienceIO through EquityZen funds. These investments are made available by existing ScienceIO shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell ScienceIO stock?
Shareholders can sell their ScienceIO stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
